| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KITE | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | Mar 01, 2017 | Sale | $75.43 | 2,400 | 181,039 | 20,864 | Mar 02, 2017, 06:05 AM | |
| KITE | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | Feb 28, 2017 | Option/RSU Exercise | $52.27 | 47,900 | 2,503,756 | 66,564 | Mar 02, 2017, 06:05 AM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Mar 01, 2017 | Sale | $80.05 | 28,882 | 2,312,004 | 117,795 | Mar 01, 2017, 09:59 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Feb 27, 2017 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 127,795 | Mar 01, 2017, 09:59 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Feb 27, 2017 | Sale | $54.42 | 10,000 | 544,178 | 123,395 | Mar 01, 2017, 09:59 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Mar 01, 2017 | Option/RSU Exercise | $1.35 | 28,882 | 38,991 | 146,677 | Mar 01, 2017, 09:59 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Feb 01, 2017 | Option/RSU Exercise | $6.89 | 1,500 | 10,335 | 22,195 | Feb 06, 2017, 04:36 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Feb 01, 2017 | Sale | $51.21 | 1,500 | 76,820 | 20,695 | Feb 06, 2017, 04:36 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Jan 31, 2017 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 127,795 | Feb 01, 2017, 07:09 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Jan 31, 2017 | Sale | $50.56 | 10,000 | 505,562 | 117,795 | Feb 01, 2017, 07:09 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Jan 06, 2017 | Option/RSU Exercise | $6.89 | 1,500 | 10,335 | 22,195 | Jan 10, 2017, 05:04 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Jan 06, 2017 | Sale | $50.00 | 1,500 | 75,000 | 20,695 | Jan 10, 2017, 05:04 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Jan 06, 2017 | Sale | $50.13 | 10,000 | 501,289 | 117,795 | Jan 10, 2017, 05:03 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Jan 06, 2017 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 127,795 | Jan 10, 2017, 05:03 PM | |
| KITE | Kite Pharma, Inc. | Arie Belldegrun | Chairman, President and CEO | Dec 09, 2016 | Gift | - | 66,000 | - | 1,607,750 | Dec 29, 2016, 05:50 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Dec 20, 2016 | Sale | $50.86 | 716 | 36,416 | 15,095 | Dec 22, 2016, 04:53 PM | |
| KITE | Kite Pharma, Inc. | Shawn Tomasello | Chief Commercial Officer | Dec 20, 2016 | Sale | $50.86 | 4,901 | 249,265 | 49,635 | Dec 22, 2016, 04:52 PM | |
| KITE | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | Dec 20, 2016 | Sale | $50.86 | 936 | 47,605 | 8,064 | Dec 22, 2016, 04:51 PM | |
| KITE | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Dec 20, 2016 | Sale | $50.86 | 1,788 | 90,938 | 25,123 | Dec 22, 2016, 04:50 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Dec 20, 2016 | Sale | $50.86 | 2,482 | 126,235 | 92,995 | Dec 22, 2016, 04:48 PM | |
| KITE | Kite Pharma, Inc. | Arie Belldegrun | Chairman, President and CEO | Dec 20, 2016 | Sale | $50.86 | 3,493 | 177,654 | 24,707 | Dec 22, 2016, 04:47 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Dec 01, 2016 | Option/RSU Exercise | $6.89 | 1,500 | 10,335 | 17,311 | Dec 05, 2016, 07:03 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Dec 01, 2016 | Sale | $50.76 | 1,500 | 76,134 | 16,018 | Dec 05, 2016, 07:03 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Nov 25, 2016 | Sale | $50.40 | 10,000 | 504,015 | 95,777 | Nov 29, 2016, 05:02 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Nov 25, 2016 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 105,477 | Nov 29, 2016, 05:02 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Nov 10, 2016 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 105,477 | Nov 14, 2016, 06:57 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Nov 10, 2016 | Sale | $50.65 | 10,000 | 506,466 | 95,887 | Nov 14, 2016, 06:57 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Nov 10, 2016 | Option/RSU Exercise | $6.89 | 1,500 | 10,335 | 17,311 | Nov 14, 2016, 06:55 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Nov 10, 2016 | Sale | $50.18 | 1,500 | 75,270 | 15,811 | Nov 14, 2016, 06:55 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Oct 03, 2016 | Option/RSU Exercise | $6.89 | 1,500 | 10,335 | 17,311 | Oct 05, 2016, 07:44 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Oct 03, 2016 | Sale | $54.81 | 1,500 | 82,214 | 15,981 | Oct 05, 2016, 07:44 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Sep 26, 2016 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 105,477 | Sep 28, 2016, 05:03 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Sep 26, 2016 | Sale | $54.13 | 10,000 | 541,300 | 95,477 | Sep 28, 2016, 05:03 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Sep 01, 2016 | Sale | $58.24 | 1,500 | 87,362 | 16,073 | Sep 02, 2016, 06:34 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Sep 01, 2016 | Option/RSU Exercise | $6.89 | 1,500 | 10,335 | 17,311 | Sep 02, 2016, 06:34 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Aug 25, 2016 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 105,477 | Aug 26, 2016, 06:38 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Aug 25, 2016 | Sale | $58.28 | 10,000 | 582,775 | 97,977 | Aug 26, 2016, 06:38 PM | |
| KITE | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | Aug 12, 2016 | Sale | $60.08 | 33,500 | 2,012,596 | 9,000 | Aug 16, 2016, 08:16 PM | |
| KITE | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | Aug 15, 2016 | Option/RSU Exercise | $51.43 | 2,400 | 123,432 | 11,400 | Aug 16, 2016, 08:16 PM | |
| KITE | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | Aug 15, 2016 | Sale | $63.01 | 2,400 | 151,229 | 9,000 | Aug 16, 2016, 08:16 PM | |
| KITE | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | Aug 12, 2016 | Option/RSU Exercise | $51.43 | 33,500 | 1,722,905 | 42,500 | Aug 16, 2016, 08:16 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Aug 01, 2016 | Option/RSU Exercise | $6.89 | 1,500 | 10,335 | 16,367 | Aug 02, 2016, 06:51 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Aug 01, 2016 | Sale | $56.90 | 1,500 | 85,343 | 15,476 | Aug 02, 2016, 06:51 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Jul 25, 2016 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 105,401 | Jul 26, 2016, 07:03 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Jul 25, 2016 | Sale | $50.94 | 10,000 | 509,350 | 95,401 | Jul 26, 2016, 07:03 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Jul 01, 2016 | Option/RSU Exercise | $6.89 | 1,500 | 10,335 | 16,367 | Jul 05, 2016, 06:27 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Jul 01, 2016 | Sale | $50.00 | 1,500 | 75,007 | 14,867 | Jul 05, 2016, 06:27 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Jun 23, 2016 | Sale | $51.28 | 10,000 | 512,754 | 95,401 | Jun 27, 2016, 07:08 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Jun 27, 2016 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 105,401 | Jun 27, 2016, 07:08 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Jun 27, 2016 | Sale | $50.15 | 10,000 | 501,484 | 95,401 | Jun 27, 2016, 07:08 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Jun 23, 2016 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 105,401 | Jun 27, 2016, 07:08 PM | |
| KITE | Kite Pharma, Inc. | Roy Doumani | Director | Jun 06, 2016 | Sale | $57.91 | 10,000 | 579,065 | 136,017 | Jun 08, 2016, 07:27 PM | |
| KITE | Kite Pharma, Inc. | Roy Doumani | Director | Jun 06, 2016 | Sale | $58.38 | 4,000 | 233,516 | 27,865 | Jun 08, 2016, 07:27 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | May 31, 2016 | Sale | $50.00 | 1,500 | 75,000 | 14,867 | Jun 02, 2016, 05:15 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Jun 01, 2016 | Option/RSU Exercise | $6.89 | 1,500 | 10,335 | 16,367 | Jun 02, 2016, 05:15 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Jun 01, 2016 | Sale | $51.30 | 1,500 | 76,949 | 15,042 | Jun 02, 2016, 05:15 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | May 31, 2016 | Option/RSU Exercise | $6.89 | 1,500 | 10,335 | 16,367 | Jun 02, 2016, 05:15 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Apr 04, 2016 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 105,401 | Apr 06, 2016, 07:06 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Apr 04, 2016 | Sale | $50.00 | 10,000 | 500,000 | 95,401 | Apr 06, 2016, 07:06 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Mar 15, 2016 | Option/RSU Exercise | $6.89 | 9,000 | 62,010 | 23,867 | Mar 17, 2016, 09:15 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Mar 15, 2016 | Sale | $44.88 | 9,000 | 403,943 | 17,125 | Mar 17, 2016, 09:15 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Mar 15, 2016 | Option/RSU Exercise | $1.35 | 8,500 | 11,475 | 18,711 | Mar 17, 2016, 09:15 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Mar 15, 2016 | Sale | $45.27 | 8,500 | 384,791 | 10,899 | Mar 17, 2016, 09:15 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Mar 15, 2016 | Option/RSU Exercise | $2.63 | 8,506 | 22,352 | 19,161 | Mar 17, 2016, 09:14 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Mar 15, 2016 | Sale | $45.23 | 8,506 | 384,766 | 11,346 | Mar 17, 2016, 09:14 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Feb 17, 2016 | Option/RSU Exercise | $2.40 | 9,632 | 23,156 | 18,730 | Mar 17, 2016, 09:13 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Mar 01, 2016 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 105,401 | Mar 03, 2016, 07:13 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Mar 01, 2016 | Sale | $50.03 | 10,000 | 500,300 | 95,401 | Mar 03, 2016, 07:13 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Feb 17, 2016 | Option/RSU Exercise | $0.70 | 9,632 | 6,742 | 18,730 | Feb 19, 2016, 04:14 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Feb 17, 2016 | Sale | $45.06 | 9,632 | 434,018 | 9,198 | Feb 19, 2016, 04:14 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Feb 17, 2016 | Sale | $45.08 | 9,567 | 431,279 | 8,841 | Feb 19, 2016, 04:13 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Feb 17, 2016 | Option/RSU Exercise | $1.35 | 9,567 | 12,915 | 18,308 | Feb 19, 2016, 04:13 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Feb 16, 2016 | Option/RSU Exercise | $6.89 | 9,000 | 62,010 | 22,742 | Feb 18, 2016, 08:34 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Feb 16, 2016 | Sale | $44.07 | 9,000 | 396,652 | 15,130 | Feb 18, 2016, 08:34 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Feb 12, 2016 | Option/RSU Exercise | $0.70 | 18,750 | 13,125 | 27,848 | Feb 16, 2016, 07:05 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Feb 12, 2016 | Sale | $64.16 | 18,750 | 1,202,964 | 9,098 | Feb 16, 2016, 07:05 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Feb 02, 2016 | Option/RSU Exercise | $1.35 | 1,900 | 2,565 | 95,907 | Feb 04, 2016, 09:06 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Feb 02, 2016 | Sale | $50.13 | 1,900 | 95,247 | 94,007 | Feb 04, 2016, 09:06 PM | |
| KITE | Kite Pharma, Inc. | Marc Better | VP, Product Sciences | Feb 01, 2016 | Option/RSU Exercise | $0.38 | 9,000 | 3,420 | 16,688 | Feb 03, 2016, 07:04 PM | |
| KITE | Kite Pharma, Inc. | Marc Better | VP, Product Sciences | Feb 01, 2016 | Sale | $47.34 | 9,000 | 426,036 | 14,189 | Feb 03, 2016, 07:04 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Jan 27, 2016 | Option/RSU Exercise | $1.35 | 8,100 | 10,935 | 102,107 | Jan 29, 2016, 06:15 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Jan 27, 2016 | Sale | $51.62 | 8,100 | 418,128 | 99,607 | Jan 29, 2016, 06:15 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Jan 15, 2016 | Option/RSU Exercise | $6.89 | 9,000 | 62,010 | 22,742 | Jan 19, 2016, 08:24 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Jan 15, 2016 | Sale | $55.26 | 9,000 | 497,379 | 22,368 | Jan 19, 2016, 08:24 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Jan 19, 2016 | Sale | $56.10 | 2,767 | 155,242 | 11,011 | Jan 19, 2016, 08:23 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Jan 15, 2016 | Option/RSU Exercise | $1.35 | 6,800 | 9,180 | 15,541 | Jan 19, 2016, 08:23 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Jan 15, 2016 | Sale | $55.23 | 6,800 | 375,589 | 15,270 | Jan 19, 2016, 08:23 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Jan 19, 2016 | Option/RSU Exercise | $1.35 | 2,767 | 3,735 | 11,508 | Jan 19, 2016, 08:23 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Jan 15, 2016 | Option/RSU Exercise | $2.41 | 6,145 | 14,815 | 15,243 | Jan 19, 2016, 08:22 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Jan 15, 2016 | Sale | $55.22 | 6,145 | 339,323 | 14,979 | Jan 19, 2016, 08:22 PM | |
| KITE | Kite Pharma, Inc. | Marc Better | VP, Product Sciences | Jan 04, 2016 | Option/RSU Exercise | $0.38 | 9,000 | 3,420 | 16,688 | Jan 05, 2016, 07:45 PM | |
| KITE | Kite Pharma, Inc. | Marc Better | VP, Product Sciences | Jan 04, 2016 | Sale | $61.53 | 9,000 | 553,788 | 14,517 | Jan 05, 2016, 07:45 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Dec 28, 2015 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 104,007 | Dec 29, 2015, 07:17 PM | |
| KITE | Kite Pharma, Inc. | Cynthia M. Butitta | COO and CFO | Dec 28, 2015 | Sale | $61.56 | 10,000 | 615,599 | 96,717 | Dec 29, 2015, 07:17 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Dec 15, 2015 | Option/RSU Exercise | $6.89 | 9,000 | 62,010 | 15,342 | Dec 17, 2015, 07:33 PM | |
| KITE | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Dec 15, 2015 | Sale | $63.78 | 9,000 | 573,989 | 12,606 | Dec 17, 2015, 07:33 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Dec 15, 2015 | Sale | $63.76 | 6,145 | 391,815 | 5,743 | Dec 17, 2015, 07:33 PM | |
| KITE | Kite Pharma, Inc. | Margo R. Roberts | Chief Scientific Officer | Dec 15, 2015 | Option/RSU Exercise | $2.41 | 6,145 | 14,815 | 8,343 | Dec 17, 2015, 07:33 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Dec 15, 2015 | Option/RSU Exercise | $1.35 | 9,567 | 12,915 | 12,508 | Dec 17, 2015, 07:32 PM | |
| KITE | Kite Pharma, Inc. | Rizwana F. Sproule | VP Regulatory Affairs | Dec 15, 2015 | Sale | $63.76 | 9,567 | 609,994 | 9,135 | Dec 17, 2015, 07:32 PM |